Shingpan Chan

Title: Shingpan Chan: Innovator in Pharmaceutical Chemistry

Introduction

Shingpan Chan is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 2-aminopyrimidine compounds. His research focuses on developing compounds that can effectively inhibit specific kinase activities, which has important implications for cancer treatment.

Latest Patents

Shingpan Chan holds a patent for a class of 2-aminopyrimidine compounds and their pharmaceutical compositions. The patent describes compounds that can efficiently and selectively inhibit the kinase activity of Janus Kinase 3 (JAK3). These compounds demonstrate strong signal inhibition and cell proliferation inhibition effects on various blood tumor cells, especially human acute myeloid leukemia cell U937 cells, as well as solid tumor cells. The potential applications of these compounds include the preparation of anti-tumor drugs and treatments for inflammatory diseases.

Career Highlights

Throughout his career, Shingpan Chan has worked with prominent organizations, including Guangzhou Salustier Biosciences Co., Ltd. and Jinan University. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in pharmaceutical research.

Collaborations

Shingpan Chan has collaborated with various professionals, including his coworker Shan Li. These collaborations have enriched his research and expanded the impact of his innovations in the pharmaceutical industry.

Conclusion

Shingpan Chan's contributions to the field of pharmaceutical chemistry, particularly through his patent on 2-aminopyrimidine compounds, highlight his role as an innovator in developing new treatments for cancer and inflammatory diseases. His work continues to influence the pharmaceutical landscape and offers hope for future medical advancements.